Tools

LEADER 03152nam a2200553 i 4500

001 on1257552450;

003 OCoLC;

005 20210630085632.0;

006 m o d f ;

007 cr |||||||||||;

008 210625s2021 dcua ob f000 0 eng c;

024 8 a| 40-555q| (GPO jacket number);

035 a| (Sirsi) o1257552450;

042 a| pcc;

043 a| n-us---;

049 a| ERE#;

050 4 a| KF27b| .E553 2019h;

074 a| 1019-C-01 (online);

086 0 a| Y 4.C 73/8:116-37;

088 a| Serial no. 116-37 (United States. Congress. House. Committee on Energy and Commerce);

245 10 a| Improving drug pricing transparency and lowering prices for American consumers :b| hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Sixteenth Congress, first session, May 21, 2019.;

264 1 a| Washington :b| U.S. Government Publishing Office,c| 2021.;

300 a| 1 online resource (vi, 187 pages) :b| color illustrations;

336 a| textb| txt2| rdacontent;

337 a| computerb| c2| rdamedia;

338 a| online resourceb| cr2| rdacarrier;

500 a| Access ID (govinfo): CHRG-116hhrg40555.;

500 a| "Serial no. 116-37.";

500 a| GPO Cataloging Record Distribution Program (CRDP).;

504 a| Includes bibliographical references.;

511 0 a| Hearing witnesses: Lisa Meengs Joldersma, Senior Vice President, Pharmaceutical Research and Manufacturers of America; Kristin Bass, Chief Policy and External Affairs Officer, Pharmaceutical Care Management Association; Madelaine Feldman, M.D., Coalition of State Rheumatology Organizations, Alliance of Specialty Medicine, President; Frederick Isasi, JD, MPH, Executive Director, Families USA; Mark Miller, Ph.D., Executive Vice President of Healthcare, Arnold Ventures; Douglas Holtz-Eakin, Ph.D., President, American Action Forum.;

518 a| Date of hearing: 2019-05-21.;

588 a| Description based on online resource; title from PDF title page (govinfo, viewed June 24, 2021).;

650 0 a| Drugsx| Pricesz| United States.=| ^A30023;

650 0 a| Pharmaceutical industryz| United States.=| ^A638;

650 0 a| Prescription pricingz| United States.=| ^A5242;

650 0 a| Prescription pricingx| Law and legislationz| United States.=| ^A867197;

650 0 a| Insurance premiumsx| Law and legislationz| United States.=| ^A1036977;

655 7 a| Legislative hearings.2| lcgft;

776 08 i| Print version:a| United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health.t| Improving drug pricing transparency and lowering prices for American consumersw| (OCoLC)1257553002;

856 40 u| https://purl.fdlp.gov/GPO/gpo156915;

922 a| GOVINFOHRG;

922 a| BIBCONEWb| 20210625;

949 a| Click on web addressw| asish| joyner94;

596 a| 1;

998 a| 5638148;

999 a| CLICK ON WEB ADDRESSw| ASISc| 1i| 5638148-1001l| JNETm| JOYNERr| Ys| Yt| JNE1DOu| 7/9/2021x| EDOCUMENTz| JERESOURCE;

Improving drug pricing transparency and lowering prices for American consumers : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Sixteenth Congress, first session, May 21, 2019.

Author/creator	United States
Format	Electronic
Publication	Washington : U.S. Government Publishing Office, 2021.
Description	1 online resource (vi, 187 pages) : color illustrations
Supplemental Content	https://purl.fdlp.gov/GPO/gpo156915
Subjects	Drugs--Prices. --United States. Pharmaceutical industry--United States. Prescription pricing--United States. Prescription pricing--Law and legislation. --United States. Insurance premiums--Law and legislation. --United States.

General note	Access ID (govinfo): CHRG-116hhrg40555.
General note	"Serial no. 116-37."
General note	GPO Cataloging Record Distribution Program (CRDP).
Bibliography note	Includes bibliographical references.
Performer	Hearing witnesses: Lisa Meengs Joldersma, Senior Vice President, Pharmaceutical Research and Manufacturers of America; Kristin Bass, Chief Policy and External Affairs Officer, Pharmaceutical Care Management Association; Madelaine Feldman, M.D., Coalition of State Rheumatology Organizations, Alliance of Specialty Medicine, President; Frederick Isasi, JD, MPH, Executive Director, Families USA; Mark Miller, Ph.D., Executive Vice President of Healthcare, Arnold Ventures; Douglas Holtz-Eakin, Ph.D., President, American Action Forum.
Date/time/place of a event note	Date of hearing: 2019-05-21.
Source of description	Description based on online resource; title from PDF title page (govinfo, viewed June 24, 2021).
Issued in other form	Print version: United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health. Improving drug pricing transparency and lowering prices for American consumers
Genre/form	Legislative hearings.
Standard identifier#	40-555 (GPO jacket number)
Technical rpt number	Serial no. 116-37 (United States. Congress. House. Committee on Energy and Commerce)
GPO item number	1019-C-01 (online)
Govt. docs number	Y 4.C 73/8:116-37

Availability

Library	Location	Call Number	Status	Item Actions
	Electronic Resources	Access Content Online	✔ Available

Improving drug pricing transparency and lowering prices for American consumers : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Sixteenth Congress, first session, May 21, 2019.

Click here for more information about this title

Availability